Linda M. Liau's most recent trade in ClearPoint Neuro Inc was a trade of 12,417 Restricted Stock Units done . Disclosure was reported to the exchange on May 22, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| ClearPoint Neuro Inc | Linda M. Liau | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2025 | 12,417 | 12,417 | - | - | Restricted Stock Units | |
| ClearPoint Neuro Inc | Linda M. Liau | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 May 2025 | 21,093 | 0 | - | - | Restricted Stock Units | |
| ClearPoint Neuro Inc | Linda M. Liau | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 May 2025 | 21,093 | 52,384 (0%) | 0% | - | Common Stock | |
| ClearPoint Neuro Inc | Linda M. Liau | Director | Grant, award, or other acquisition of securities at price $ 15.38 per share. | 02 Jan 2025 | 193 | 31,291 (0%) | 0% | 15.4 | 2,968 | Common Stock |
| ClearPoint Neuro Inc | Linda M. Liau | Director | Grant, award, or other acquisition of securities at price $ 11.21 per share. | 01 Oct 2024 | 264 | 31,098 (0%) | 0% | 11.2 | 2,959 | Common Stock |
| ClearPoint Neuro Inc | Linda M. Liau | Director | Grant, award, or other acquisition of securities at price $ 5.39 per share. | 01 Jul 2024 | 550 | 30,834 (0%) | 0% | 5.4 | 2,965 | Common Stock |
| ClearPoint Neuro Inc | Linda M. Liau | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2024 | 21,093 | 21,093 | - | - | Restricted Stock Units | |
| ClearPoint Neuro Inc | Linda M. Liau | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 May 2024 | 17,153 | 30,284 (0%) | 0% | - | Common Stock | |
| ClearPoint Neuro Inc | Linda M. Liau | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 May 2024 | 17,153 | 0 | - | - | Restricted Stock Units | |
| ClearPoint Neuro Inc | Linda M. Liau | Director | Grant, award, or other acquisition of securities at price $ 6.80 per share. | 01 Apr 2024 | 436 | 13,131 (0%) | 0% | 6.8 | 2,965 | Common Stock |
| ClearPoint Neuro Inc | Linda M. Liau | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2023 | 17,153 | 17,153 | - | - | Restricted Stock Units | |
| ClearPoint Neuro Inc | Linda M. Liau | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2022 | 9,269 | 12,695 (0%) | 0% | 0 | Common Stock | |
| ClearPoint Neuro Inc | Linda M. Liau | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2022 | 6,179 | 6,179 | - | - | Stock Options (right to buy) | |
| ClearPoint Neuro Inc | Linda M. Liau | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Nov 2021 | 6,696 | 6,696 | - | - | Stock Options (right to buy) | |
| ClearPoint Neuro Inc | Linda M. Liau | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Nov 2021 | 3,426 | 3,426 (0%) | 0% | 0 | Common Stock |